GSK Investigational Site

Ourense 32005

1 studies enrolling now · 4 studies all time

What they study most

Myelodysplastic Syndromes, Nausea, Nausea and Vomiting, Chemotherapy-Induced, Neoplasms, Breast, Neoplasms, Head and Neck, Vomiting

Studies at this site

• A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome — Recruiting now
• Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer — Completed
• Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery — Completed
• Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting — Completed